Archive for January, 2009

The Money Times

Eli Lilly pleads guilty to 'off-label' drug marketingCNNMoney.com - Jan 30, 2009NEW YORK (CNN) — Pharmaceutical giant Eli Lilly and Company pleaded guilty Friday to a misdemeanor charge of marketing one of its medicines for uses not …Eli Lilly pleads guilty in marketing case Philadelphia InquirerEli Lilly & Co. Q4 2008 Earnings Call Transcript [...]

Dividend.com

Bristol-Myers Squibb AnnouncesZacks.com, IL - Jan 27, 2009This morning Bristol-Myers Squibb (BMY) announced financial results for the 4th quarter and issued 2009 financial guidance. Fourth quarter revenue of .25 …Bristol-Myers Squibb turns to profit in Q4 - Quick Facts 1 RTT NewsBristol-Myers Squibb Company F4Q08 and Full Year Earnings Call … Seeking AlphaStrong Fourth Quarter Supports [...]

ABC News

Pfizer Will Pay Wyeth .5 Billion if Lenders Quash PurchaseBloomberg - Jan 29, 2009The drugmaker must pay Wyeth the .5 billion breakup fee if the lenders pull out of the deal. The lenders may act if Pfizer’s operations decline a …Video: Pfizer buys Wyeth ReutersVideoPfizer deal gives Wyeth say on board, breakup fee The Associated [...]

FDA Says Abbott's Depakote Promotion Is MisleadingCNNMoney.com - Jan 30, 2009By Jared A. Favole WASHINGTON -(Dow Jones)- Federal regulators have sent a letter to Abbott Laboratories (ABT) warning the company that promotional material …Mylan gets FDA approval on generic Depakote ER ForbesFDA Sends Abbott Letter Regarding Depakote ER/Depakote Continuum … PharmaLive.com (press release)Mylan Receives FDA Approval [...]

Merck seeks new medicine uses, cutting jobs againForbes, NY - 23 hours agoAP , 01.30.09, 03:49 PM EST Merck & Co., a Dow component and the world's No. 8 drugmaker by revenue, reports earnings for the fourth quarter on Tuesday …Lawsuit: Cholesterol-Lowering Drug Ads Misleading WCCOSchering downgraded on cholesterol market concerns Forbesall 7 news articles

Sanofi-Aventis CEO plans acquisitions -union repReuters - Jan 30, 2009PARIS, Jan 30 (Reuters) - French drug maker Sanofi-Aventis's (SASY.PA) new Chief Executive Chris Viehbacher has told staff he plans to make acquisitions and …

Citigroup, Merrill, Novartis May Drop Satyam Deals, Times SaysBloomberg - 15 hours ago31 (Bloomberg) — Citigroup Inc., Merrill Lynch & Co., Novartis AG and GlaxoSmithKline Plc may cancel contracts worth more than 0 million with India’s …Citi, Merrill, Novartis, GSK may shift Satyam contracts Economic Timesall 5 news articles

GlaxoSmithKline hires Eli Lilly executive as new North American …Bizjournals.com, NC - Jan 30, 2009Pharmaceutical giant GlaxoSmithKline has hired a new leader for its Triangle-based US operations, raiding rival Eli Lilly & Co. in the process. …Glaxo Appoints Connelly To Head Pharmaceutical Operations In North … CNNMoney.comDeirdre Connelly to Lead Glaxo's US Operations Wall Street JournalGlaxo taps [...]

Nationally Recognized Medicaid Fraud Prosecutor Tim Terry Joins …PR Web (press release), WA - Jan 29, 2009"Tim's spearheaded Medicaid fraud settlements against some of the largest health care companies in America, including Abbott, Bayer, ColumbiaHCA, Dey, …

BBC News

Suits Saying Pfizer Experimented on Nigerian Children Are RevivedWashington Post, United States - 15 hours agoBy Joe Stephens A federal appeals court on Friday revived two lawsuits brought against Pfizer by Nigerian families who say the giant drugmaker used their …Pfizer faces NY lawsuits over human medical tests MSNBCLawsuit Against Pfizer May Proceed WNYCNigerians' Pfizer case [...]